Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Recruiting · NCT06606028 · Registry updated 2025-12-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, skin squamous cell carcinoma, squamous cell carcinoma | Recruiting | Not stated | 2025-12-12 | NCT06606028 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haystack Oncology, Inc. | 4 |
| University of California, San Francisco | 637 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California, San Francisco | San Francisco | United States | 294 |